Inventor · disambiguated record
Kenneth Stephen Koblan
Also filed as: KOBLAN KENNETH · KOBLAN KENNETH S · KOBLAN KENNETH STEPHEN
12 granted patents·6 pending applications·97 citations·filing 1993–2024
91Inventor score
Top patents by PatentIndex Score
18 records- 0197US10874639B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 29, 2020·8 cites·30 claims
- 0297US10660875B1Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted May 26, 2020·10 cites·24 claims
- 0395US10369134B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·14 cites·29 claims
- 0494US10576058B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2019·Granted Mar 3, 2020·10 cites·6 claims
- 0593US11517558B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2020·Granted Dec 6, 2022·2 cites·20 claims
- 0689US11129807B2Methods of treating schizophreniaSUNOVION PHARMACEUTICALS INC·Filed 2018·Granted Sep 28, 2021·5 cites·22 claims
- 0784US12161623B2Nonracemic mixtures and uses thereofSUNOVION PHARMACEUTICALS INC·Filed 2022·Granted Dec 10, 2024·0 cites·15 claims
- 0879US6838291B2Radioligand and binding assayMERCK & CO INC·Filed 2001·Granted Jan 4, 2005·8 cites·16 claims
- 0971US5519163AInhibitors of phosphoinositide-specific phospholipase CMERCK & CO INC·Filed 1993·Granted May 21, 1996·25 cites·6 claims
- 1070US2025057806A1Methods of treating schizophreniaSUMITOMO PHARMA AMERICA INC·Filed 2024·Application pending·0 cites
- 1164US2022062229A1Methods of treating schizophreniaSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1262US7193070B2Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methodsMERCK & CO INC·Filed 2002·Granted Mar 20, 2007·10 cites·8 claims
- 1355US2023241024A1Methods of treating metabolic disordersSUNOVION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1452US2006003985A1Enhancement of sleep with t-type calcium channel antagonistsRENGER JOHN J·Filed 2003·Application pending·0 cites
- 1544US2004106773A1Human tuberoinfundibular peptide of 39 residuesFiled 2001·Application pending·0 cites
- 1638US5474921AExpression and purification of phosphoinositide-specific phospholipase C-γMERCK & CO INC·Filed 1993·Granted Dec 12, 1995·5 cites·1 claims
- 1737US10076503B2Dosage of dasotraline and method for treatment of ADHDSUNOVION PHARMACEUTICALS INC·Filed 2015·Granted Sep 18, 2018·0 cites·3 claims
- 1835US2017266133A1Methods and compositions of dasotraline for treatment of adhdSUNOVION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →